Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2023-12-21 Director's Dealing
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Medistim ASA - Disclosure of large shareholding and transaction by close associate
Director's Dealing Classification · 99% confidence The document text details a transaction involving shares of Medistim ASA by a 'person closely associated' with a board member (Anthea Arff-Pettersen). Specifically, it reports the 'Disposal/transfer of shares by way of capital contribution in kind' by Aeternum Capital AS. This structure, detailing the person, the issuer, the nature of the transaction, price, volume, and date, is characteristic of mandatory insider trading disclosures, often referred to as Director's Dealing reports in many jurisdictions (like MAR in the EU). This aligns perfectly with the definition for Director's Dealing (DIRS).
2023-12-21 English
Medistim ASA - Disclosure of large shareholding and transaction by close associate
Director's Dealing Classification · 98% confidence The document explicitly announces a 'Disclosure of large shareholding and transaction by close associate' involving Medistim ASA. It details the transfer of shares in a subsidiary (HoldCo) which results in a change in the indirect holding of Medistim ASA shares, specifically noting that WQZ Investment Group Ltd. will hold approximately 10.36% of the shares and votes. Furthermore, it mentions that Aeternum Capital AS is a closely associated person of a primary insider (Anthea Arff-Pettersen) and refers to an attached form for further details, which is typical for insider transaction reporting under regulations like MAR Article 19. This content directly aligns with the definition of 'Director's Dealing' or insider transaction reporting, which corresponds to the 'Director's Dealing (DIRS)' code, as it concerns transactions by parties closely associated with insiders.
2023-12-21 English
Major shareholder disclosure in Medistim ASA by Danske Bank AS
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'Major shareholder disclosure' and details that Danske Bank Group's aggregated holding in Medistim ASA has fallen below the 5% threshold, specifying the exact number of shares and the resulting percentage (4.76%). This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2023-11-15 English
Management in Medistim ASA purchases shares – correction
Director's Dealing Classification · 99% confidence The document text explicitly details the purchase of shares by a member of management (VP sales EMEA Stephanie Stenhagen) in Medistim ASA, including the number of shares purchased and the resulting holding. This directly corresponds to the definition of Director's Dealing (insider trades by executives). The document is short and appears to be a notification correcting a previous announcement about this transaction. Therefore, the appropriate classification is DIRS (Director's Dealing).
2023-11-14 English
Management in Medistim ASA purchases shares
Director's Dealing Classification · 98% confidence The document explicitly details the purchase of shares by members of the management team (VP sales, CBDO, CEO, CFO, etc.) in Medistim ASA. It lists the number of shares purchased by each individual and their resulting holdings. This directly corresponds to the definition of 'Director's Dealing' or insider transactions, which is classified as 'DIRS' (Director's Dealing). Although the company also sold some own shares, the primary focus and structure of the announcement is reporting management transactions.
2023-11-13 English
Medistim is opening a direct sales office in Sweden
Regulatory Filings Classification · 100% confidence The document is a short press release dated October 31, 2023, announcing that Medistim ASA is opening a direct sales office in Sweden as part of its global growth strategy. It details operational changes, management structure for the new subsidiary, and acknowledges a former distributor. This type of announcement, which details operational or strategic business updates rather than financial results (ER, IR), management changes (MANG), or capital structure changes (CAP), fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). It is too specific for RNS but lacks the required detail for other categories like MANG or CAP. Given the content is a general business update/announcement, RNS is the most appropriate fallback, although it could potentially be considered a type of Investor Relations announcement, RNS covers general regulatory/market announcements.
2023-10-31 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.